Orqis Closes Series D

Orqis Medical Corp., a Lake Forrest, Calif.-based developer of minimally-invasive cardiac recovery devices, has raised $12 million in additional Series D funding. This brings the round total to $34.7 million, including a first close from late 2005. New backers include Wasatch Advisors, Wasatch affiliate Cross Creek Capital and the Omega Fund. Existing shareholders include HealthCare Ventures, Care Capital, Rho Ventures, Domain Associates, Boston Scientific, Johnson & Johnson Development Corp. and Temasek Holdings. www.orqis.com